Scorpion's RevenueMAX Wins BIG Innovation Award
Scorpion is thrilled to announce its recognition as a winner in the prestigious 2025 BIG Innovation Awards, presented by the ...
pharmaphorum10h
Pharma holds it breath for ’25 as the sun shines on JP Morgan conference
The word on San Francisco’s famously hilly streets is that big pharma is ready to go shopping in 2025, following a flurry of ...
stockhead19h
Health Check: The urge to merge is spurring a global biotech recovery
Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.
Relay Therapeutics Inc (RLAY): AI-Driven Cancer Treatments Backed by Barclays’ $17 Price Target
Relay Therapeutics Inc. (NASDAQ:RLAY) is a leading clinical-stage precision medicines firm focused on cancer treatments. The ...
Investing News Network on MSN5d
Biotech Market Forecast: Top Trends for Biotech in 2025
The biotech sector in 2025 presents a landscape brimming with both opportunities and challenges. The industry is being shaped ...
Chemistry World6d
J&J’s Intra-Cellular deal could signal more mega-mergers for 2025
The J&J deal would be the biggest biotech deal in over a year and will add treatments for disorders of the central nervous ...
Odyssey Therapeutics Begins IPO Rollout
Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...